Evidence map›Paper›PMID 28814780›Full record

ArticleScientific reports2017

Adaptive simulations, towards interactive protein-ligand modeling.

Daniel Lecina, Joan F Gilabert, Victor Guallar

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. EngineeringiScience · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Selective inhibitors of the PSEN1-gamma-secretase complex.The Journal of biological chemistry · 2023
    Article
  15. Article
  16. Recent PELE Developments and Applications in Drug Discovery Campaigns.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Article
  19. Review
  20. Structural basis for substrate specificity of heteromeric transporters of neutral amino acids.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniel LecinaBarcelona Supercomputing Center (BSC), Jordi Girona 29, E-08034, Barcelona, Spain.
Joan F GilabertBarcelona Supercomputing Center (BSC), Jordi Girona 29, E-08034, Barcelona, Spain.
Victor GuallarBarcelona Supercomputing Center (BSC), Jordi Girona 29, E-08034, Barcelona, Spain. victor.guallar@bsc.es.
Barcelona Supercomputing Center · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modeling the dynamic nature of protein-ligand binding with atomistic simulations is one of the main challenges in computational biophysics, with important implications in the drug design process. Although in the past few years hardware and software advances have significantly revamped the use of molecular simulations, we still lack a fast and accurate ab initio description of the binding mechanism in complex systems, available only for up-to-date techniques and requiring several hours or days of heavy computation. Such delay is one of the main limiting factors for a larger penetration of protein dynamics modeling in the pharmaceutical industry. Here we present a game-changing technology, opening up the way for fast reliable simulations of protein dynamics by combining an adaptive reinforcement learning procedure with Monte Carlo sampling in the frame of modern multi-core computational resources. We show remarkable performance in mapping the protein-ligand energy landscape, being able to reproduce the full binding mechanism in less than half an hour, or the active site induced fit in less than 5 minutes. We exemplify our method by studying diverse complex targets, including nuclear hormone receptors and GPCRs, demonstrating the potential of using the new adaptive technique in screening and lead optimization studies.

Indexed as

LigandsMolecular Dynamics SimulationProtein ConformationSoftwareAlgorithmsDrug DesignMonte Carlo MethodProtein BindingProteinsLigandsProteins

Identifiers

PMID28814780
PMCPMC5559483
OpenAlexW2743816750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.